CoChat

Evaluation of Serum Diamine Oxidase as a Diagnostic Test for Histamine Intolerance

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.

Abstract

Histamine intolerance (HIT) is a clinical condition caused by decreased intestinal degradation of ingested histamine, primarily due to reduced enzyme diamine oxidase (DAO) activity, leading to histamine accumulation and causing various clinical manifestations. The measurement of serum DAO is commonly used as the main diagnostic test for HIT, although its diagnostic use is still uncertain. In this retrospective study, we aimed to assess the validity of DAO determination in patients with clinically suspected HIT. We measured DAO levels in 249 patients with suspected HIT and 50 healthy adult controls without HIT-related problems. Based on five clinical criteria, we divided patients into two groups: high (all five inclusion criteria; 41 patients) and low probability of HIT (≤4 inclusion criteria; 208 patients). Patients with a “high probability of HIT” had the lowest DAO (median: 8 U/mL, IQR: 6–10) in comparison to patients with a “low probability of HIT (median: 10 U/mL, IQR: 7–16, p = 0.0006) and healthy controls (median: 18 U/mL, IQR: 14–22, p < 0.0001). The specificity and sensitivity for DAO levels < 3/< 10 U/mL (manufacturer’s set cut-off) to discriminate between patients with ‘‘high probability of HIT’’ and healthy controls were 100%/92% and 2%/71%. On the other hand, the specificity and sensitivity to discriminate between patients with ‘‘high probability of HIT’’ and ‘‘low probability of HIT’’ were 97%/61% and 2%/71%, respectively. Serum DAO determination represents an additional asset to the diagnosis of HIT based on clinical evaluation and assessment, but the diagnosis should not solely rely on DAO measurements.

Overview

CoChat Summary

## TL;DR

This retrospective study found that serum diamine oxidase (DAO) was lower in patients with a high clinical probability of histamine intolerance (HIT) than in low-probability patients and healthy controls. DAO measurement distinguished high-probability HIT from healthy controls well, but it was much less useful for separating high- from low-probability HIT, so it should be only an adjunct to clinical diagnosis.

## Key findings

  • Among 249 patients with suspected HIT, 41 (16%) were classified as “high probability of HIT” and 208 (84%) as “low probability of HIT”; 50 healthy controls were also included.
  • Median serum DAO was lowest in the high-probability group: 8 U/mL (IQR 6–10), versus 10 U/mL (IQR 7–16) in low-probability patients and 18 U/mL (IQR 14–22) in healthy controls.
  • Using the manufacturer’s reference ranges, specificity was 100% for DAO <3 U/mL and 92% for DAO <10 U/mL; sensitivity was 2% for <3 U/mL and 71% for <10 U/mL.
  • DAO was most accurate for distinguishing high-probability HIT from healthy controls: AUC 0.872 (95% CI 0.79–0.95), sensitivity 93% (95% CI 81–97%), specificity 76% (95% CI 63–86%), cut-off 13.5 U/mL.
  • Discrimination between high- and low-probability HIT was limited: AUC 0.667 (95% CI 0.58–0.75), sensitivity 71% (95% CI 56–82%), specificity 61% (95% CI 54–67%), cut-off 9.5 U/mL.

## Methods

  • Retrospective study at the University Clinic of Respiratory and Allergic Diseases Golnik; patients were enrolled from November 2017 to December 2020 and classified by five clinical inclusion criteria into high- or low-probability HIT groups.
  • Final sample: 249 adult patients with suspected HIT and 50 age- and sex-matched healthy adult controls; 21 patients were excluded for insufficient clinical data and 30 for secondary HIT (lactose intolerance/celiac disease).
  • Serum DAO was measured by quantitative ELISA (IDK DAO ELISA), and group comparisons plus ROC curve analysis were used to assess diagnostic performance.

## Limitations

  • The paper states that only one DAO measurement per patient was performed, which may be limited by overlap between groups due to food intake and elimination diets.
  • The paper states that it is unknown how serum DAO concentration correlates with intestinal DAO concentration, and whether the correlation is significant.
  • Evident from the text: the study was retrospective and used clinical classification of HIT rather than an independent gold-standard diagnostic test, so diagnostic accuracy is judged against clinical probability groups rather than definitive confirmed HIT.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu15194246

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Number of “low probability of HIT” patients based on the number of inclusion criteria fulfilled.
Figure 1 Number of “low probability of HIT” patients based on the number of inclusion criteria fulfilled.CC BY · PubMed Central
Figure 2 Serum DAO levels in patients with suspected HIT and healthy controls. The data are presented as medians with an interquartile range. Mann-Whitney; *** p < 0.001, **** p < 0.0001.
Figure 2 Serum DAO levels in patients with suspected HIT and healthy controls. The data are presented as medians with an interquartile range. Mann-Whitney; *** p < 0.001, **** p < 0.0001.CC BY · PubMed Central
Figure 3 ROC curves comparing the discriminating performance of DAO.
Figure 3 ROC curves comparing the discriminating performance of DAO.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 10 Not checked · 18 Own results and interpretations

9 more claims

Create a free account to see all 32 claims and to verify the 15 references still open.

See all claims — free account
  • It may state two separate claims as one. 12
  • Probably not a substantial claim. 7

Create a free account to see these claims.

Citations

Cites

Show all 19 references

Research works printed but not linked: 1

  1. Seifert, 2008, Histamine intolerance: Is the determination of diamine oxidase activity in the serum useful in routine clinical practice?, Allergologie, 31, 350

Cited by

Metadata

Authors
Arih, K., Đorđević, N., Košnik, M., & Rijavec, M.
Affiliations
University of Ljubljana (SI)
Corresponding author
Rijavec, Matija
Venue
Nutrients
Publisher
MDPI AG
Published
2023-10-02
Volume
15
Issue
19
Pages
4246
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4387264754
Cited by
20
References
19
Citations by year
2026: 4 · 2025: 11 · 2024: 5
FWCI
2.18
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository of the University of Ljubljana (University of Ljubljana) (submittedVersion, cc-by)
Funders
Slovenian Research and Innovation Agency (P3-0360)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
histamine intolerance, diamine oxidase, diagnostic test validity, sensitivity and specificity, histamine accumulation, clinical criteria, cut-off values
MeSH terms
Adult, Diagnostic Tests, Routine, Amine Oxidase (Copper-Containing), Histamine, Humans, Retrospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.